| Literature DB >> 16307680 |
Mirjam I Bakker1, Linda May, Mochammad Hatta, Agnes Kwenang, Paul R Klatser, Linda Oskam, Jeanine J Houwing-Duistermaat.
Abstract
BACKGROUND: It is generally accepted that genetic factors play a role in susceptibility to both leprosy per se and leprosy type, but only few studies have tempted to quantify this. Estimating the contribution of genetic factors to clustering of leprosy within families is difficult since these persons often share the same environment. The first aim of this study was to test which correlation structure (genetic, household or spatial) gives the best explanation for the distribution of leprosy patients and seropositive persons and second to quantify the role of genetic factors in the occurrence of leprosy and seropositivity.Entities:
Mesh:
Year: 2005 PMID: 16307680 PMCID: PMC1318483 DOI: 10.1186/1471-2350-6-40
Source DB: PubMed Journal: BMC Med Genet ISSN: 1471-2350 Impact factor: 2.103
Characteristics of study population in June 2000
| n | % | |
| Persons living on Kembanglemari | 634 | |
| Persons screened for leprosy | 560 | 88.3 |
| Persons screened for antibodies | 432 | 68.1 |
| Persons included in pedigrees | 589 | 92.9 |
| Leprosy status | ||
| No leprosy | 529 | 94.5 |
| PB1a leprosy | 13 | 2.3 |
| PB2-5b leprosy | 3 | 0.5 |
| MBc leprosy | 12 | 1.9 |
| RFTd (no classification available) | 3 | 0.5 |
| Serological status | ||
| Seronegative | 395 | 91.4 |
| Seropositive | 37 | 8.6 |
a PB1 = single lesion paucibacillary leprosy
b PB2-5 = paucibacillary leprosy with 2–5 lesions
c MB = multibacillary leprosy
d RFT = released from treatment
Leprosy and seroprevalence per agegroup
| Age group (years) | Screened for leprosy | RFTa | MB Leprosyb | PB Leprosyc | Leprosy N (%) | Tested for IgM | Seropositive N (%) |
| 0–5 | 122 | 0 | 0 | 0 | 0 | 7 | 1 (14.3) |
| 6–20 | 219 | 0 | 4 | 8 | 12 (5.5) | 211 | 24 (11.4) |
| 21–39 | 136 | 2 | 5 | 5 | 12 (8.8) | 133 | 9 (6.8) |
| 40–59 | 57 | 1 | 3 | 0 | 4 (7.0) | 55 | 1 (1.8) |
| ≥60 | 26 | 0 | 0 | 3 | 3 (11.5) | 26 | 2 (7.7) |
| Total | 560 | 3 | 12 | 16 | 31 (5.5) | 432 | 37 (8.6) |
a RFT = released from treatment
b MB = multibacillary leprosy
c PB = paucibacillary leprosy
Figure 1Map of Kembanglemari Island showing the new patients per house. = 0, ● = 1, = 2, + = 3 new patients. Not all houses without patients are shown.
Figure 2Map of Kembanglemari Island showing the seropositive persons per house. = 0, ● = 1, = 2, + = 3 seropositive persons. Not all houses without seropositive persons are shown.
Figure 3Part of the extended pedigree of family one, showing family relations between leprosy patients.
P-values for testing the null hypothesis of no clustering of leprosy per se, MB leprosy, PB leprosy and of seropositivity due to genetic, household and spatial effects.
| N | (sero)preve. | Genetic | Household | Spatial | |
| Leprosy | 560 | 5.5% | 0.084 | 0.145 | |
| MBa leprosy | 541c | 2.2% | 0.105 | ||
| PBb leprosy | 545d | 2.9% | 0.311 | 0.154 | 0.555 |
| Seropositivity | 432 | 8.6% | 0.118 | ||
| Leprosy | 424 | 4.5% | |||
Test-statistic is adjusted for age and sex.
Italic: p-value <0.05; Bold: best fitting model
a MB = multibacillary leprosy; b PB = paucibacillary leprosy
c 541 = 560 - 3 RFT patients - 16 PB patients
d 545 = 560 - 3 RFT patients - 12 MB patients
e (sero)prev = leprosy prevalence or seroprevalence